Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Go back to Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c

March 27, 2025 4:09 PM EDT

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

... More